임상시험 용품 시장 규모, 점유율, 동향 분석 보고서 : 임상 단계별, 제품 및 서비스별, 최종 용도별, 치료 분야별, 지역별, 부문 예측(2025-2030년)

Clinical Trial Supplies Market Growth & Trends:

The global clinical trial supplies market size is estimated to reach USD 4.10 billion in 2030 and is anticipated to grow at a compound annual growth rate CAGR of 7.19% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing volume of clinical trial studies coupled with the growing complexity in conduction of these trials are some of the major factors driving the market growth.

Globally, an increase in the prevalence of chronic diseases and the rapidly aging population are expected to drive the growth of R&D of biologics, which is expected to further propel the demand for efficient clinical supplies and contribute to the growth of the clinical trial supplies industry. Furthermore, an increase in the demand for orphan drugs and high investment in the R&D of rare diseases are also expected to contribute toward the development of biologic drugs. Thus, owing to these factors, this segment is likely to witness significant growth during the forecast period.

For instance, in 2022, Novartis invested around USD 10 billion in research and development. It also secured 23 approvals in the European Union, Japan, China, and the U.S. for new drugs and rare diseases. The company is also conducting 44 ongoing phase III programs in India with 17 clinical programs running in rare diseases such as atypical hemolytic uremic syndrome (aHUS), Immune thrombocytopenic purpura (ITP), spinal muscular atrophy (SMA), and Lupus Nephritis.

Direct-to-Patients (DTP) is an upcoming segment in the distribution of clinical trial supplies, which is expected to be the future model of distribution. DTP is one of the emerging models that involves delivering drugs to patients directly to create patient-centric trials. This would facilitate fewer visits to the site and reduce the burden on participants. The COVID-19 outbreak has led to the increased adoption of such a model, to continue clinical trial studies with minimum disruption. In addition, patient retention and a diverse pool of patients worldwide are some of the notable reasons that can be attributed to the high adoption of this model.

Clinical Trial Supplies Market Report Highlights:

• Based on the clinical phase, the market is anticipated to be dominated by the Phase III trial segment with a 53.03% revenue share in 2024. The presence of a large number of molecules currently under Phase III makes it the primary factor responsible for this deduction
• Among services, the storage, and distribution segment is anticipated to witness the fastest growth at a CAGR of 7.54% during the forecast period. The rise in global biologics pipeline and temperature-sensitive drugs is expected to increase the complexities related to the logistics of clinical trial supplies
• Biologics are expected to witness the fastest growth at 7.48% CAGR during the forecast period owing to the increasing research in the field of genetics and biotechnology such as the development of nanoparticle-based drug delivery systems
• In terms of therapeutic use, oncology dominated the market with a revenue share of 39.59% in 2024. According to the United Press International, hospitals in the U.S. are disposing of billions of cancer drug vials due to improper dosage, thereby indicating the need for appropriate supply management

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Regional Scope
  • 1.1.2. Estimates and Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Purchased Database
  • 1.3.3. GVR's Internal Database
  • 1.3.4. Secondary Sources
  • 1.3.5. Primary Research
• 1.4. Information or Data Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Validation
  • 1.5.1. Region Wise Market: Base Estimates
  • 1.5.2. Global Market: CAGR Calculation
• 1.6. Model Details
  • 1.6.1. Commodity Flow Analysis (Model 1)
  • 1.6.2. Value-Chain-Based Sizing & Forecasting (Model 2)
  • 1.6.3. QFD Model Sizing & Forecasting (Model 3)
  • 1.6.4. Bottom-Up Approach (Model 4)
• 1.7. List of Secondary Sources
• 1.8. List of Abbreviations
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regulatory Framework

Chapter 3. Clinical Trial Supplies Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Expansion of Clinical Trials Sites
    • 3.2.1.2. Growing R&D in Biologics and Biosimilars
    • 3.2.1.3. Advancements in Supply Chain Technology
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. Presence of Stringent Regulatory Policies
    • 3.2.2.2. High Possibility of Counterfeiting Drugs
• 3.3. Technological Advancements
  • 3.3.1. Integration of AI and Digital Technologies
• 3.4. Pricing Model Analysis
• 3.5. Clinical Trials Volume Analysis, 2024
  • 3.5.1. Total Number of Clinical Trials, by Region (2024)
  • 3.5.2. Total Number of Clinical Trials, by Phase (2024)
  • 3.5.3. Total Number of Clinical Trials, by Study Design (2024)
  • 3.5.4. Total Number of Clinical Trials, by Key Therapeutic Area (2024)
• 3.6. Market Analysis Tools
  • 3.6.1. Porter's Five Forces Analysis
  • 3.6.2. PESTEL by SWOT Analysis
  • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Supplies Market: Clinical Phase Estimates & Trend Analysis

• 4.1. Clinical Trial Supplies Market, By Clinical Phase: Segment Dashboard
• 4.2. Clinical Trial Supplies Market, By Clinical Phase: Movement Analysis
• 4.3. Clinical Trial Supplies Market Estimates & Forecasts, By Clinical Phase, 2018 - 2030 (USD Million)
• 4.4. Phase I
  • 4.4.1. Phase I Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 4.5. Phase II
  • 4.5.1. Phase II Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 4.6. Phase III
  • 4.6.1. Phase III Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Others Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Clinical Trial Supplies Market: Product & Service Estimates & Trend Analysis

• 5.1. Clinical Trial Supplies Market, By Product & Service: Segment Dashboard
• 5.2. Clinical Trial Supplies Market, By Product & Service: Movement Analysis
• 5.3. Clinical Trial Supplies Market Estimates & Forecasts, By Product & Service, 2018 - 2030 (USD Million)
• 5.4. Manufacturing
  • 5.4.1. Manufacturing Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. Storage & Distribution
    • 5.4.2.1. Downstream processing Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2.2. Cold Chain Distribution
      • 5.4.2.2.1. Cold Chain Distribution Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2.3. Non-Cold Chain Distribution
      • 5.4.2.3.1. Non-Cold Chain Distribution Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 5.4.3. Supply Chain Management
    • 5.4.3.1. Supply Chain Management Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Clinical Trial Supplies Market: Therapeutic Area Estimates & Trend Analysis

• 6.1. Clinical Trial Supplies Market, By Therapeutic Area: Segment Dashboard
• 6.2. Clinical Trial Supplies Market, By Therapeutic Area: Movement Analysis
• 6.3. Clinical Trial Supplies Market Estimates & Forecasts, By Therapeutic Area, 2018 - 2030 (USD Million)
• 6.4. Oncology
  • 6.4.1. Oncology Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 6.5. CNS Diseases
  • 6.5.1. CNS Diseases Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 6.6. Cardiovascular Diseases
  • 6.6.1. Cardiovascular Diseases Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 6.7. Infectious Disease
  • 6.7.1. Infectious Disease Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 6.8. Metabolic Disorders
  • 6.8.1. Metabolic Disorders Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 6.9. Others
  • 6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Clinical Trial Supplies Market: End Use Estimates & Trend Analysis

• 7.1. Clinical Trial Supplies Market, By End Use: Segment Dashboard
• 7.2. Clinical Trial Supplies Market, By End Use: Movement Analysis
• 7.3. Clinical Trial Supplies Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
• 7.4. Pharmaceutical
  • 7.4.1. Pharmaceutical Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 7.5. Biologics
  • 7.5.1. Oncology Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 7.6. Medical Devices
  • 7.6.1. Medical Devices Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Clinical Trial Supplies Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. North America
  • 8.4.1. North America Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. U.S. Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Canada Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. Mexico Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. UK Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Germany Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. France Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Italy Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Spain Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Denmark
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Denmark Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competitive Scenario
    • 8.5.8.3. Regulatory Framework
    • 8.5.8.4. Sweden Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competitive Scenario
    • 8.5.9.3. Regulatory Framework
    • 8.5.9.4. Norway Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. China
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. China Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. Japan
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Japan Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. India Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Australia Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competitive Scenario
    • 8.6.6.3. Regulatory Framework
    • 8.6.6.4. South Korea Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competitive Scenario
    • 8.6.7.3. Regulatory Framework
    • 8.6.7.4. Thailand Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. Brazil Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Argentina Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.8. Middle East and Africa
  • 8.8.1. Middle East and Africa Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competitive Scenario
    • 8.8.2.3. Regulatory Framework
    • 8.8.2.4. South Africa Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competitive Scenario
    • 8.8.3.3. Regulatory Framework
    • 8.8.3.4. Saudi Arabia Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competitive Scenario
    • 8.8.4.3. Regulatory Framework
    • 8.8.4.4. UAE Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competitive Scenario
    • 8.8.5.3. Regulatory Framework
    • 8.8.5.4. Kuwait Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Company Profiles
  • 9.2.1. Almac Group
    • 9.2.1.1. Participant's Overview
    • 9.2.1.2. Financial Performance
    • 9.2.1.3. Service Benchmarking
    • 9.2.1.4. Strategic Initiatives
  • 9.2.2. Biocair
    • 9.2.2.1. Participant's Overview
    • 9.2.2.2. Financial Performance
    • 9.2.2.3. Service Benchmarking
    • 9.2.2.4. Strategic Initiatives
  • 9.2.3. Catalent, Inc.
    • 9.2.3.1. Participant's Overview
    • 9.2.3.2. Financial Performance
    • 9.2.3.3. Service Benchmarking
    • 9.2.3.4. Strategic Initiatives
  • 9.2.4. KLIFO
    • 9.2.4.1. Participant's Overview
    • 9.2.4.2. Financial Performance
    • 9.2.4.3. Service Benchmarking
    • 9.2.4.4. Strategic Initiatives
  • 9.2.5. Movianto
    • 9.2.5.1. Participant's Overview
    • 9.2.5.2. Financial Performance
    • 9.2.5.3. Service Benchmarking
    • 9.2.5.4. Strategic Initiatives
  • 9.2.6. PCI Pharma Services
    • 9.2.6.1. Participant's Overview
    • 9.2.6.2. Financial Performance
    • 9.2.6.3. Service Benchmarking
    • 9.2.6.4. Strategic Initiatives
  • 9.2.7. Sharp Services, LLC
    • 9.2.7.1. Participant's Overview
    • 9.2.7.2. Financial Performance
    • 9.2.7.3. Service Benchmarking
    • 9.2.7.4. Strategic Initiatives
  • 9.2.8. Thermo Fisher Scientific, Inc.
    • 9.2.8.1. Participant's Overview
    • 9.2.8.2. Financial Performance
    • 9.2.8.3. Service Benchmarking
    • 9.2.8.4. Strategic Initiatives
  • 9.2.9. UPS Healthcare
    • 9.2.9.1. Participant's Overview
    • 9.2.9.2. Financial Performance
    • 9.2.9.3. Service Benchmarking
    • 9.2.9.4. Strategic Initiatives
  • 9.2.10. Paraxel International Corporation
    • 9.2.10.1. Participant's Overview
    • 9.2.10.2. Financial Performance
    • 9.2.10.3. Service Benchmarking
    • 9.2.10.4. Strategic Initiatives